Abstract
Clinical epidemiological research is an important approach within Individualized Medicine. This research allows for the identification of possible biomarkers for specific diseases through the use of data from clinical treatments. From a research ethical point of view it needs to be noted that respective studies are mostly very complex. Therefore a variety of different normative requirements of both ethical and legal natures need to be met. On the one hand those studies aim for the scientific use of clinical records. On the other hand samples of biomaterial are to be collected, stored and analyzed using -omics methods. Sometimes there are also study examinations included in these studies which may produce incidental findings.
In this chapter a possible solution shall be demonstrated which meets the mentioned requirements: the informed consent process of the GANI_MED project. By presenting the consent documents design process and their different sections, it can be shown that a good ethical standard can be assured throughout the entire process while providing data from different sources to clinical epidemiological research. Furthermore the response patterns of the patients participating in the GANI_MED project will be presented. The data demonstrate that a possibility to deselect certain aspects of the study through the sectional consent documents is actually used by the participants. The data also show that the patients of different morbidity cohorts answer in a different way.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Appelbaum PS, Lidz CW, Grisso T (2004) Therapeutic misconception in clinical research: frequency and risk factors. IRB: Ethics & Human Research 26(2):1–8
Back AL, Arnold RM, Baile WF et al (2005) Approaching difficult communication tasks in oncology. CA Cancer J Clin 55:164–177
Baile WF, Buckmann R, Lenzi R et al (2000) SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. The Oncologist 5:302–311
Bundesdatenschutzgesetz in der Fassung der Bekanntmachung vom 14. Januar 2003 (BGBl. I S. 66), das zuletzt durch Artikel 1 des Gesetzes vom 14. August 2009 (BGBl. I S. 2814) geändert worden ist (2009). http://www.gesetze-im-internet.de/bundesrecht/bdsg_1990/gesamt.pdf. Accessed 22 May 2014
Ehling J, Vogeler M (2008) Der Probandenvertrag. MedR 26:273–281
Erdmann P (2014) Zufallsbefunde aus bildgebenden Verfahren in populationsbasierter Forschung: Eine empirisch–ethische Untersuchung. Mentis, Münster (forthcoming)
Fallowfield L, Jenkins V (2004) Communicating sad, bad, and difficult news in medicine. The Lancet 363:312–319
Fallowfield L, Jenkins V, Farewell V et al (2002) Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomized controlled trial. The Lancet 359:650–656
Gesetz zum Schutz des Bürgers bei der Verarbeitung seiner Daten (Landesdatenschutzgesetz—DSG M-V) Vom 28. März 2002 Mehrfach geändert durch Artikel 2 des Gesetzes vom 20. Mai 2011 (GVOBl. M-V S. 277, 278) (2011). http://www.landesrecht-mv.de/jportal/portal/page/bsmvprod.psml?showdoccase=1&doc.id=jlr-DSGMVrahmen&doc.part=X&doc.origin=bs. Accessed 22 May 2014
Grabe HJ, Assel H, Bahls T et al (2014) Cohort profile: Greifswald Approach to Individualized Medicine (GANI_MED). J Transl Med 12(144)
Grundgesetz für die Bundesrepublik Deutschland vom 23. Mai 1949 (BGBl. S. 1), zuletzt geändert durch das Gesetz vom 11. Juli 2012 (BGBl. I S. 1478) (2012). http://www.bundestag.de/bundestag/aufgaben/rechtsgrundlagen/grundgesetz/. Accessed 22 May 2014
Heinrichs B (2011) A new challenge for research ethics: Incidental findings in neuroimaging. Bioeth Inquiry 8:59–65
Hoffmann M, Schmücker R (2010) Die ethische Problematik der Zufallsbefunde. In: Puls R, Hosten N (eds) Ganzkörper-MRT-Screening. Befunde und Zufallsbefunde. ABW Wissenschaftsverlag, Berlin, pp 1–16
Hüsing B, Hartig J, Bührlen B et al (2008) Individualisierte Medizin und Gesundheitssystem, TAB-Arbeitsbericht Nr. 126. https://www.tab-beim-bundestag.de/de/pdf/publikationen/berichte/TAB-Arbeitsbericht-ab126.pdf. Accessed 27 Juni 2014
Kamlah W (1973) Philosophische Anthropologie. Sprachkritische Grundlegung und Ethik. Bibliographisches Institut, Mannheim
Kurtz SM (2002) Doctor-patient communication: principles and practices. Can J Neurol Sci 29 (suppl. 2):23–29
Langanke M, Erdmann P (2011) Die MRT als wissenschaftliche Studienuntersuchung und das Problem der Mitteilung von Zufallsbefunden: Probandenethische Herausforderungen. In: Theissen H, Langanke M (eds) Tragfähige Rede von Gott. Festgabe für Heinrich Assel zum 50. Geburtstag 9. Februar 2011. Verlag Dr. Kovač, Hamburg, pp 198–240
Langanke M, Brothers KB, Erdmann P et al (2011) Comparing different scientific approaches to personalized medicine: research ethics and privacy protection. Personalized Med 8(4):437–444
Langanke M, Erdmann P, Dörr M et al (2012) Gesundheitsökonomische Forschung im Kontext Individualisierter Medizin: Forschungsethische und datenschutzrechtliche Aspekte am Beispiel des GANI_MED-Projekts. Pharmacoeconomics Ger Res Articles 10(2):105–121
Puls R, Hamm B, Hosten, N (2010) MRT ohne Radiologen—ethische Aspekte bei bevölkerungsbasierten Studien mit MR-Untersuchung. Fortschr Röntgenstr 182:469–471
Reng CM, Debold P, Specker C et al (2006) Generische Lösungen der TMF zum Datenschutz für die Forschungsnetze in der Medizin. Im Auftrag des Koordinierungsrates der Telematikplattform für Medizinische Forschungsnetze. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin
Rudnik-Schöneborn S, Langanke M, Erdmann P et al (2014) Ethische und rechtliche Aspekte im Umgang mit genetischen Zufallsbefunden: Herausforderungen und Lösungsansätze. Ethik in der Medizin 26(2):105–119
Schleidgen S, Klingler C, Bertram T et al (2013) What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Medical Ethics 14:55
Strafgesetzbuch in der Fassung der Bekanntmachung vom 13. November 1998 (BGBl. I S. 3322), das zuletzt durch Artikel 1 des Gesetzes vom 23. April 2014 (BGBl. I S. 410) geändert worden ist (2014). http://www.gesetze-im-internet.de/bundesrecht/stgb/gesamt.pdf. Accessed 22 May 2014
WMA Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964 and amended by the: 29th WMA General Assembly, Tokyo, Japan, October 1975, 35th WMA General Assembly, Venice, Italy, October 1983, 41st WMA General Assembly, Hong Kong, September 1989, 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996, 52nd WMA General Assembly, Edinburgh, Scotland, October 2000, 53rd WMA General Assembly, Washington DC, USA, October 2002 (Note of Clarification added), 55th WMA General Assembly, Tokyo, Japan, October 2004 (Note of Clarification added), 59th WMA General Assembly, Seoul, Republic of Korea, October 2008, 64th WMA General Assembly, Fortaleza, Brazil, October 2013 (2013). http://www.wma.net/en/30publications/10policies/b3/. Accessed 22 May 2014
Wolf SM (2008) The challenge of incidental findings. J Law Med Ethics 36:216–218
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Fasold, J., Erdmann, P., Lorbeer, R., Liedtke, W., Langanke, M. (2015). Informed Consent in GANI_MED—A Sectional Design for Clinical Epidemiological Studies Within Individualized Medicine. In: Fischer, T., Langanke, M., Marschall, P., Michl, S. (eds) Individualized Medicine. Advances in Predictive, Preventive and Personalised Medicine, vol 7. Springer, Cham. https://doi.org/10.1007/978-3-319-11719-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-11719-5_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11718-8
Online ISBN: 978-3-319-11719-5
eBook Packages: MedicineMedicine (R0)